Navigation Links
Biopharma Leaders to Discuss and Share Insights on the Regional Biopharma Ecosystem at LeadingBiotech’s NY/NJ CEO Conference
Date:10/17/2019

LeadingBiotech, an exclusive event series bringing together senior-level biopharma leaders through off-the-record collaboration and dialogue, today announces its NY/NJ CEO conference to be held on November 5, 2019 at Apella by Alexandria in New York, NY.

The event offers senior-level industry leaders a unique opportunity to collaborate, build partnerships and share insights through candid panel discussions with peers. C-level executives, VPs and partners can participate in forums on pressing industry issues and biopharma business development, centering on the New York biopharma ecosystem.

“The NY/NJ conference convenes executive-level biopharma leaders in this region to discuss broad industry issues as well as issues directly impacting the New York ecosystem,” said Wendy Nelson, Ph.D., CEO, LeadingBiotech.

To secure a spot at the conference, register here.

Key new topics at this year’s conference include, The New Wave of NY Biotech; Company Building: Choosing HQ, Workforce and Company Culture; Accelerating Gene Therapies to the Patient; and Issues in Board Development for Biotech CEOs.

Keynote speakers at the conference include:

  • Liz Barrett, CEO, UroGen Pharma
  • James Flynn, Managing Partner, Deerfield Management
  • Allison Jeynes-Ellis, CEO, Avillion
  • Gordana Vunjak-Novakovic, University Professor, Mikati Foundation Professor, Biomedical Engineering and Medicine Director, Laboratory for Stem Cells and Tissue Engineering, Columbia University

Other speakers include:

  • Thomas Brennan, Partner, Arch Ventures
  • Sammy Farah, CEO, Turnstone Biologics
  • Erik Lium, Ph.D., EVP, MT Sinai Innovation Partners
  • Maria Mitchell, Ph.D., SVP, Life Sciences, Empire State Development
  • Gaurav Shah, President & CEO, Rocket Pharma
  • Erika Smith, CEO, ReNetX Bio
  • Nancy Thornberry, CEO, Kallyope
  • Misti Ushio, Ph.D., CEO, TARA Biosystems
  • Ben Zeskind, Ph.D., Co-Founder and CEO, Immuneering Corporation

See full agenda here.

About LeadingBiotech
Formerly known as Boston Biotech Conferences, LeadingBiotech is an event series that brings biopharma CEOs and leaders together through intimate, off-the-record collaboration. We are working hard to create more valuable experiences to re-energize collaboration and infuse fresh ideas to better shape the future of biotech. For more information, please visit: https://leadingbiotech.com/.

Read the full story at https://www.prweb.com/releases/biopharma_leaders_to_discuss_and_share_insights_on_the_regional_biopharma_ecosystem_at_leadingbiotechs_ny_nj_ceo_conference/prweb16650364.htm.


'/>"/>
Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved


Related biology news :

1. Biopharmaceutical Cold Chain Engineering Firm Modality Solutions Makes Inc. 5000 List of America’s Fastest-Growing Companies
2. Biopharma Leaders Convene to Discuss Topics in Biotech, Healthcare and Innovation at LeadingBiotech’s Inaugural South CEO Conference
3. AbSci Appoints Biopharmaceutical Pioneer Dr. Fred Larimore to Executive Team
4. VetStem Biopharma is Pleased to Announce that Dr. Julie Reck of Veterinary Medical Center of Fort Mill is Now Providing VetStem Regenerative Cell Therapy
5. VetStem Biopharma Secures FDA Approval of First Human IND for its Subsidiary, Personalized Stem Cells, Inc.
6. Fluid Imaging Technologies announces FlowCam VisualSpreadsheet Software Release 5 Strategically Aligned with Automation Trends in Biopharmaceutical Industry
7. VetStem Biopharma Enters Pet Cancer Field with Key License from Leading Human Cancer Company, Calidi Biotherapeutics
8. VetStem Biopharma Shares the Success Story of Seve who was Treated with VetStem Cell Therapy by Dr. Cindy Echevarria
9. VetStem Biopharma Shares the Success Story of Harper who was Treated with VetStem Cell Therapy by Dr. Christopher Eich
10. VetStem Biopharma is Pleased to Share the Success Story of Ava who was Treated with VetStem Cell Therapy by Dr. David Luck
11. Greenberg Traurig Hosts Boston Healthcare Drinks and Discussion on China Biopharma Industry
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2019)... ... , ... SiteSeer Technologies, creator of SiteSeer Professional retail site selection software, is ... SiteSeer. The boutique real estate developer of single and multi-tenant buildings on sites ranging ... own analysis of markets. , Geoffrey Kerth, manager of GPK Acquisitions, says that ...
(Date:11/6/2019)... ... 06, 2019 , ... In October, Massachusetts stem cell biotechnology ... about a poorly disclosed deficiency in stem cell treatments. Throughout stem cell ... treating stem cells. This problem affects all patients receiving stem cell treatments, ...
(Date:11/2/2019)... Ill. (PRWEB) , ... October 31, 2019 , ... In ... forward with a successful career in research and consulting. , The Beyond the Lab ... Its episodes feature interviews from alumni who have jobs in the biomedical field — ...
Breaking Biology News(10 mins):
(Date:10/10/2019)... ... October 09, 2019 , ... The ... Principal Deputy Commissioner, FDA, as a newly-confirmed keynote speaker for the 2019 ... Vegas, Nevada USA. , Dr. Abernethy, a hematologist/oncologist and palliative medicine physician, is ...
(Date:10/10/2019)... VEGAS (PRWEB) , ... October 10, 2019 , ... R3 ... courses. The next course is October 18-19th, 2019 in Las Vegas with spots still ... exosomes. He completed training at several Ivy League universities including Cornell, Harvard and Dartmouth. ...
(Date:10/8/2019)... ... October 08, 2019 , ... ... Madhumita Suresh and Leslie Maurer presented company executives with a set of recommendations ... (MBS) graduates will offer insights from their TMP to a wider audience of ...
(Date:10/8/2019)... ... ... Today, Massachusetts stem cell biotechnology company Asymmetrex announces the recent patenting ... approved in the U.S. in 2017, the new patent covers the company’s unique technology ... technology in the U.S. as the AlphaSTEM Test™. The new patent will support ...
Breaking Biology Technology: